Latest Feature

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

BrainScope wins FDA clearance for Ahead 100 brain-injury scanner

November 21, 2014 by Val Kennedy

BrainScope wins U.S. regulatory clearance for its Ahead 100 device for detecting traumatic brain injury.

BrainScope wins FDA approval for Ahead 100 brain-injury scanner

BrainScope said it won 510(k) clearance from the FDA for its Ahead 100 device, designed to detect traumatic brain injury.

Covidien wins home-use CE Mark for Nellcor oxygen monitor

November 21, 2014 by Val Kennedy

Covidien says it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Covidien wins CE Mark for Nellcor oxygen monitor

Covidien (NYSE:COV) said it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

MassDevice.com +3 | The top 3 medtech stories for November 21, 2014

November 21, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Could cyber crooks really hack your pacemaker?

November 21, 2014 by MassDevice

Pacemakers get hacked on TV, but could it happen in real life?

Could cyber crooks really hack your pacemaker?

Kaiser Health News — Jay Radcliffe breaks into medical devices for a living, testing for vulnerabilities as a security researcher.

He's also a diabetic, and gives himself insulin injections instead of relying on an automated insulin pump, which he says could be hacked.

BD-CareFusion deal passes US anti-trust waiting period

November 21, 2014 by Mark Hollmer

Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.

BD-CareFusion deal passes US anti-trust waiting period

Startup Aortica raises $7m in Series A round, names Douthitt CEO

November 21, 2014 by Brad Perriello

Aortica raises $7 million in a Series A funding round for its customized abdominal aortic aneurysm device and names medtech veteran Tom Douthitt as its new CEO.

Aortica raises $7m in Series A round, names new CEO

Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.

Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.

Medtronic realigns diabetes unit

November 21, 2014 by Brad Perriello

Medtronic reshapes its diabetes business into 3 divisions 'focused on transforming diabetes care,' CEO Omar Ishrak said this week.

Medtronic realigns diabetes unit

Medtronic (NYSE:MDT) said this week that it realigned its diabetes business to focus on "transforming diabetes care," according to CEO Omar Ishrak.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp